427 / | HD | COATING PROCESSES |
|
2.1 | DF | MEDICAL OR DENTAL PURPOSE PRODUCT; PARTS; SUBCOMBINATIONS; INTERMEDIATES (E.G., BALLOON CATHETER, SPLINT) {7} |
2.14 | | .~ Particulate or unit-dosage-article base (e.g., tablet, pill, pellet, capsule, liposome, powder, controlled-release implant, suppository; excluding transdermal patch) {5} |
2.15 | DF | .~.~> Fluidized bed utilized {2} |
2.18 | DF | .~.~> En masse rotating means employed (e.g., rotating pan, tumbling) {2} |
2.21 | DF | .~.~> Retarded or controlled-release layer produced (e.g., enteric) |
2.22 | DF | .~.~> Gelatin matrix layer produced |
2.23 | DF | .~.~> Significant color or other intended appearance altering layer formed (e.g., shining, indicia) |